Paramjit Kaur

Paramjit Kaur is an experienced professional with a strong background in the pharmaceutical industry, focusing on Clinical Science and Strategy, Clinical Operations, and Medical Affairs.

With expertise in designing, planning, and executing clinical development strategies across a range of studies and submissions, Paramjit has proven success in areas such as TPPs, CDPs, and Life Cycle Management activities.

Skilled in Good Clinical Practice (GCP) and adept at creating operational models for matrix-based teams, she has worked in various therapy areas like Oncology and Virology.

Adaptable and driven by challenges, Paramjit has honed valuable matrix skills through her roles in both large and small companies, emphasizing team development and a curious mindset.

Educationally, Paramjit studied at the prestigious University of Cambridge.

Her professional journey includes key roles such as Global Clinical Program Lead & Culture and Engagement Lead at AstraZeneca, with previous positions as a Global Development Lead in Oncology and Medical Science, Oncology at the same company.

Prior to her time at AstraZeneca, Paramjit served in leadership roles at organizations like Clovis Oncology, Vertex Pharmaceuticals, Bristol-Myers Squibb, Dainippon Sumitomo Pharma, and GSK.

Paramjit Kaur's career highlights her expertise in clinical development, leadership, team management, and a commitment to continuous learning and improvement.